Clinical Trial

CD70-targeted immunoPET Imaging of Kidney Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to establish and optimize the \[18F\]RCCB6 PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agent in renal cancer (especially clear cell renal cell carcinoma) wil be evaluated.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-06; most recent amendment 2025-12-25.
Trial Details
NCT Number NCT06680089
Lead Sponsor RenJi Hospital
Conditions Urologic Neoplasms, Urogenital Neoplasms, Kidney Neoplasms, Neoplasms
Enrollment 300 participants
Start Date 2024-11-27
Primary Completion 2026-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-31